These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 32372138)
21. A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma. Gao X; Tang M; Tian S; Li J; Liu W Future Oncol; 2021 Apr; 17(12):1533-1544. PubMed ID: 33432837 [TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma. Fan T; Liu Y; Liu H; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J Cancer Immunol Immunother; 2021 Dec; 70(12):3651-3667. PubMed ID: 33977344 [TBL] [Abstract][Full Text] [Related]
23. The screening of immune-related biomarkers for prognosis of lung adenocarcinoma. Liu Z; Sun D; Zhu Q; Liu X Bioengineered; 2021 Dec; 12(1):1273-1285. PubMed ID: 33870858 [TBL] [Abstract][Full Text] [Related]
24. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma. Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610 [TBL] [Abstract][Full Text] [Related]
25. Prognostic model of lung adenocarcinoma constructed by the CENPA complex genes is closely related to immune infiltration. Zhou H; Bian T; Qian L; Zhao C; Zhang W; Zheng M; Zhou H; Liu L; Sun H; Li X; Zhang J; Liu Y Pathol Res Pract; 2021 Dec; 228():153680. PubMed ID: 34798483 [TBL] [Abstract][Full Text] [Related]
26. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma. Fang L; Yu W; Yu G; Zhong F; Ye B Med Sci Monit; 2022 Jan; 28():e933503. PubMed ID: 35034089 [TBL] [Abstract][Full Text] [Related]
27. Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma. Aizemaiti R; Wu Z; Tang J; Yan H; Lv X Int J Med Sci; 2021; 18(2):448-458. PubMed ID: 33390814 [TBL] [Abstract][Full Text] [Related]
28. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma. Zhou J; Wang X; Li Z; Jiang R FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810 [TBL] [Abstract][Full Text] [Related]
29. Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitors. Davoodi-Moghaddam Z; Jafari-Raddani F; Kordasti S; Bashash D J Egypt Natl Canc Inst; 2024 Oct; 36(1):30. PubMed ID: 39370456 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma. Cui Y; Li Y; Long S; Xu Y; Liu X; Sun Z; Sun Y; Hu J; Li X BMC Med Genomics; 2023 Aug; 16(1):184. PubMed ID: 37553698 [TBL] [Abstract][Full Text] [Related]
31. NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma. Chen X; Zhang T; He YQ; Miao TW; Yin J; Ding Q; Yang M; Chen FY; Zeng HP; Liu J; Zhu Q BMC Pulm Med; 2024 May; 24(1):248. PubMed ID: 38764064 [TBL] [Abstract][Full Text] [Related]
32. Prognostic and immunotherapeutic implications of bilirubin metabolism-associated genes in lung adenocarcinoma. Ren K; Ling X; Chen L; Li Z; Huang T J Cell Mol Med; 2024 May; 28(9):e18346. PubMed ID: 38693853 [TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma. Pan Y; Sha Y; Wang H; Zhuang H; Ren X; Zhu X; Wei X J Cancer Res Ther; 2020; 16(2):320-326. PubMed ID: 32474519 [TBL] [Abstract][Full Text] [Related]
34. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma. Song Q; Shang J; Yang Z; Zhang L; Zhang C; Chen J; Wu X J Transl Med; 2019 Mar; 17(1):70. PubMed ID: 30832680 [TBL] [Abstract][Full Text] [Related]
35. Six CT83-related Genes-based Prognostic Signature for Lung Adenocarcinoma. Wang Y; Zhang G; Wang R Comb Chem High Throughput Screen; 2022; 25(9):1565-1575. PubMed ID: 34259140 [TBL] [Abstract][Full Text] [Related]
36. Multi‑omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma. Xu S; Chen X; Ying H; Chen J; Ye M; Lin Z; Zhang X; Shen T; Li Z; Zheng Y; Zhang D; Ke Y; Chen Z; Lu Z BMC Cancer; 2024 Sep; 24(1):1138. PubMed ID: 39267056 [TBL] [Abstract][Full Text] [Related]
37. Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma. Li J; Li Q; Su Z; Sun Q; Zhao Y; Feng T; Jiang J; Zhang F; Ma H Lipids Health Dis; 2020 Oct; 19(1):222. PubMed ID: 33050938 [TBL] [Abstract][Full Text] [Related]
38. Exploring exosome data to identify prognostic gene signatures for lung adenocarcinoma. Li J; Gao X; Tian S; Tang M; Liu W Future Oncol; 2021 Dec; 17(34):4745-4756. PubMed ID: 34658257 [TBL] [Abstract][Full Text] [Related]
39. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
40. Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinoma. Wu D; Liu Y; Liu J; Ma L; Tong X Sci Rep; 2024 Jul; 14(1):17460. PubMed ID: 39075165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]